Diagnostic and Interventional Cardiology

Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD)

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

July 10, 2024

Keith Churchwell, M.D., FAHA, has been named new volunteer president at the American Heart Association for fiscal year 2024-2025.

News | AHA

American Heart Association Announces New 2024-2025 National Volunteer Leaders

July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...

July 09, 2024

Counties tend to be more rural and socioeconomically disadvantaged

News | Cardiovascular Business

Almost Half of US Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

July 09, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY Endovascular Robotic Surgical System

News | Cardiovascular Clinical Studies

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

July 09, 2024

News | Atrial Fibrillation

Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation Patients

July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...

July 08, 2024

News | Structural Heart

Webinar on Optimizing Structural Heart Workflows to Take Place Next Week

On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows ...

July 08, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

During the American Heart Association Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2024 taking place in Chicago this week, two new, basic research studies in rodents (mice and rats) analyzed the impacts that alcohol may have on the heart.

News | AHA

New Research on Alcohol’s Impact on the Heart at American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024

July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS ...

July 05, 2024

Feature | Cardiovascular Business

Happy 4th from the DAIC team

The DAIC team wishes you a safe and happy 4th of July!

July 04, 2024

Researchers call for monitoring of quality, outcomes in era of private equity ownership

News | Cardiovascular Business

Study: Private Equity Acquisitions in Cardiology on the Rise

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

July 03, 2024

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in heart transplantation, heart failure, and other complex cardiac conditions

News | Structural Heart

Cedars-Sinai Cardiologist Leads the American Society of Transplantation

July 3, 2024 — Jon Kobashigawa, MD, director of the Heart Transplant Program in the Department of Cardiology in the ...

July 03, 2024

Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels

News | Stents Drug Eluting

Biotronik Introduces Expanded Maximum Diameter Dimensions for Orsiro Mission DES

July 2, 2024 — Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro ...

July 02, 2024

News | FDA

FDA Issues Left Ventricular Assist System (LVAS) Monitor Correction: Abbott Issues Correction for HeartMate LVAS System Monitor due to Screen Issues that May Cause Unintentional Pump Stop

July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its ...

July 02, 2024

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

DAIC's Top 10 for June

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

July 02, 2024

Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer

News | Cardiovascular Business

CVRx Announces Key Senior Leadership Team Hires

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

July 01, 2024

The program aims to improve health outcomes, with a focus on increasing awareness of the symptoms and risks of hypertension

News | Hypertension

Expansion of AstraZeneca’s Flagship Health Equity Program Healthy Heart Africa

June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative ...

June 28, 2024